Thus, TET2 protein has been implicated in the development of hematological malignancies such as acute myeloid leukemia (AML), chronic myelomonocytic leukemia (CMML), and Myelodysplastic syndrome (MDS) (Tefferi et al., 2009). The gene discussed is TET2; the disease is chronic myelomonocytic leukemia.